Status Epilepticus: Stopping runaway seizures with a chill pill
The neuropeptide neurotensin can reduce status epilepticus and its associated consequences through induction of therapeutic hypothermia when bound to a molecule that can penetrate the blood-brain barrier.
- University of Iowa, Carver College of Medicine, United States
The brain consists of electrically excitable cells called neurons, which work in concert to regulate brain function. Sometimes, these cells become aberrantly connected and may activate together as a small network, leading to abnormal bursts of electrical activity known as seizures. Seizures disrupt the flow of messages between neurons and can lead to involuntary changes in behavior, sensation, and body movement or function.
Recurrent seizures are the hallmark of disease in patients with epilepsy (Langbein et al., 2024). Seizures that last a long time, also known as status epilepticus, can be life-threatening and require immediate treatment. Unfortunately, status epilepticus is often very difficult to control, leading to a high rate of morbidity and mortality (Kämppi et al., 2024).
Efforts to develop better therapies for status epilepticus are ongoing (O’Kula and Hill, 2024; Kishihara et al., 2024). One way to manage these kinds of seizures involves inducing hypothermia in the body and the brain to reduce cellular excitability (Kirmani et al., 2021). However, lowering body temperature using physical means, such as cooling blankets or infusions of cooled saline, can negatively affect the body. A more targeted way would be through medication that could pharmacologically alter body temperature.
While drugs targeting the biochemical pathways that regulate temperature homeostasis can lower body temperature, they often fail to reach the brain due to the blood-brain barrier, a protective semipermeable membrane between the blood and the brain. Thus, many drugs that lower body temperature do not markedly reduce brain temperature and have little to no effect on status epilepticus. Now, in eLife, Lotfi Ferhat, Michel Khrestchatisky and colleagues report a new approach to specifically reduce brain temperature and stop status epilepticus (Ferhat et al., 2024).
The researchers, who are based at various research institutes in France, targeted the biochemical pathway involving the signaling molecule neurotensin, which is known to regulate body temperature by lowering the set point on the thermostat that governs body temperature. As neurotensin cannot cross the blood-brain barrier, Ferhat et al. combined neurotensin with a molecule known to penetrate the brain and tested its effectiveness in mice. Specifically, these ‘conjugated’ versions were able to bind the low-density lipoprotein receptor (LDLR), which then transported the molecule across the blood-brain barrier intothe brain.
The researchers developed several conjugate proteins, and through a series of careful testing, identified one to employ throughout the study. The conjugate formed by this protein and neurotensin was successful in reaching the brain, inducing hypothermia, and reducing the seizures and cognitive and inflammatory changes associated with status epilepticus. However, it still needs to be confirmed that neurotensin-induced hypothermia alone is responsible for alleviating the effects associated with status epilepticus.
Regardless, the possibility of pharmacologically induced hypothermia for managing status epilepticus is exciting. Refractory status epilepticus (which continues despite treatment) is a dreadful condition with extremely high rates of mortality, despite the barrage of currently available therapies. Improved treatment modalities are sorely needed. While the findings of Ferhat et al. are promising, more needs to be learned about the safety of these treatments for the rest of the body. Such studies could be first trialled in animals but would later need to be replicated in humans. Moreover, while it is assumed that pharmacological means to induce hypothermia would have fewer negative consequences than physical means, this needs to be empirically evaluated. Hypothermia itself can have profound negative consequences, so the degree of hypothermia would need to be tightly monitored (Lu et al., 2024).
The extent of neuroprotection afforded by pharmacologically induced hypothermia could likely extend to other forms of neural injury, including stroke, post-anoxic brain injury or traumatic brain injury (Lin et al., 2024). Thus, implications for this promising work are potentially extremely far-reaching.
References
-
Mortality and morbidity of status epilepticus over the long termEpilepsy & Behavior 158:109918.https://doi.org/10.1016/j.yebeh.2024.109918
-
Super-refractory status epilepticus: prognosis and recent advances in managementAging and Disease 12:1097–1119.https://doi.org/10.14336/AD.2021.0302
-
Efficacy of second-line anticonvulsant agents with adult status epilepticus: A systematic review and network meta-analysisThe American Journal of Emergency Medicine 82:183–189.https://doi.org/10.1016/j.ajem.2024.06.019
-
Therapeutic approaches targeting seizure networksFrontiers in Network Physiology 4:1441983.https://doi.org/10.3389/fnetp.2024.1441983
-
Temperature control in acute brain injury: An updateSeminars in Neurology 44:308–323.https://doi.org/10.1055/s-0044-1785647
-
Severe hypothermia induces ferroptosis in cerebral cortical nerve cellsInternational Journal of Molecular Sciences 25:8086.https://doi.org/10.3390/ijms25158086
-
Improving quality of care for status epilepticus: Putting protocols into practiceCurrent Neurology and Neuroscience Reports 24:373–379.https://doi.org/10.1007/s11910-024-01356-9
Article and author information
Author details
Publication history
Copyright
© 2024, Buchanan
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 330
- views
-
- 29
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Status Epilepticus: Stopping runaway seizures with a chill pill
eLife 13:e102055.
https://doi.org/10.7554/eLife.102055
Further reading
-
- Neuroscience
Predicting an individual’s cognitive traits or clinical condition using brain signals is a central goal in modern neuroscience. This is commonly done using either structural aspects, such as structural connectivity or cortical thickness, or aggregated measures of brain activity that average over time. But these approaches are missing a central aspect of brain function: the unique ways in which an individual’s brain activity unfolds over time. One reason why these dynamic patterns are not usually considered is that they have to be described by complex, high-dimensional models; and it is unclear how best to use these models for prediction. We here propose an approach that describes dynamic functional connectivity and amplitude patterns using a Hidden Markov model (HMM) and combines it with the Fisher kernel, which can be used to predict individual traits. The Fisher kernel is constructed from the HMM in a mathematically principled manner, thereby preserving the structure of the underlying model. We show here, in fMRI data, that the HMM-Fisher kernel approach is accurate and reliable. We compare the Fisher kernel to other prediction methods, both time-varying and time-averaged functional connectivity-based models. Our approach leverages information about an individual’s time-varying amplitude and functional connectivity for prediction and has broad applications in cognitive neuroscience and personalised medicine.
-
- Neuroscience
Non-linear summation of synaptic inputs to the dendrites of pyramidal neurons has been proposed to increase the computation capacity of neurons through coincidence detection, signal amplification, and additional logic operations such as XOR. Supralinear dendritic integration has been documented extensively in principal neurons, mediated by several voltage-dependent conductances. It has also been reported in parvalbumin-positive hippocampal basket cells, in dendrites innervated by feedback excitatory synapses. Whether other interneurons, which support feed-forward or feedback inhibition of principal neuron dendrites, also exhibit local non-linear integration of synaptic excitation is not known. Here, we use patch-clamp electrophysiology, and two-photon calcium imaging and glutamate uncaging, to show that supralinear dendritic integration of near-synchronous spatially clustered glutamate-receptor mediated depolarization occurs in NDNF-positive neurogliaform cells and oriens-lacunosum moleculare interneurons in the mouse hippocampus. Supralinear summation was detected via recordings of somatic depolarizations elicited by uncaging of glutamate on dendritic fragments, and, in neurogliaform cells, by concurrent imaging of dendritic calcium transients. Supralinearity was abolished by blocking NMDA receptors (NMDARs) but resisted blockade of voltage-gated sodium channels. Blocking L-type calcium channels abolished supralinear calcium signalling but only had a minor effect on voltage supralinearity. Dendritic boosting of spatially clustered synaptic signals argues for previously unappreciated computational complexity in dendrite-projecting inhibitory cells of the hippocampus.
